Article Details

Inhibikase Therapeutics, Inc. Announces Pricing of its Initial Public Offering

Retrieved on: 2020-12-22 23:26:15

Tags for this article:

Click the tags to see associated articles and topics

Inhibikase Therapeutics, Inc. Announces Pricing of its Initial Public Offering. View article details on hiswai:

Excerpt

In addition, Inhibikase has granted the underwriters a 45-day option to purchase up to an additional 270,000 shares of common stock at the initial ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up